Large granular lymphocytosis

Haematologica

Volumn 83, Issue 10, 1998, Pages 936-942

  Zambello, Renato ^a   Semenzato, Gianpietro ^b  

^a Vicenza Hospital   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Cytotoxic cells; Granular lymphocytes; Lymphocytosis; Lymphoproliferative disease of granular lymphocytes

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; METHOTREXATE; PREDNISONE;

ANEMIA; CLINICAL FEATURE; CLONOGENESIS; COMBINATION CHEMOTHERAPY; DEMOGRAPHY; DISEASE CLASSIFICATION; DISEASE COURSE; DOSE RESPONSE; EPSTEIN BARR VIRUS; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOSTIMULATION; LARGE GRANULAR LYMPHOCYTE; LYMPHOCYTOSIS; LYMPHOPROLIFERATIVE DISEASE; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PROGNOSIS; REVIEW; VIRUS INFECTION;

HUMANS; LYMPHOCYTOSIS; LYMPHOPROLIFERATIVE DISORDERS;

EID: 0031733722     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Trinchieri G. Biology of human natural killer cells. Adv Immunol 1989; 47:187-376.
2. Phillips JH, Lanier LL. Lectin-dependent and anti-CD3 induced cytotoxicity are preferentially mediated by peripheral blood cytotoxic T lymphocytes expressing Leu7 antigen. J Immunol 1986; 136:1579-84.
3. McKenna RW, Parkin J, Kersey JH, Gajl-Peczalska KJ, Peterson L, Brunning RD. Chronic lymphoproliferative disorder with unusual clinical, morphologic, ultrastructural and membrane surface marker characteristics. Am J Med 1977; 62:588-96.
4. Loughran, TP Jr. Clonal diseases of large granular lymphocytes. Blood 1993, 82:1-14.
5. Semenzato G, Pandolfi F, Chisesi T, et al. The lymphoproliferative disease of granular lymphocytes. A heterogeneous disorder ranging from indolent to aggressive conditions. Cancer 1987; 60:2971-8.
6. Oshimi K, Yamada O, Kaneko T, et al. Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders. Leukemia 1993; 7:782-91.
7. Dhodapkar MV, Li CY, Lust JA, Tefferi A, Phyliky RL. Clinical spectrum of clonal proliferations of T-large granular lymphocytes: A T cell clonopathy of undetermined significance? Blood 1994; 84:1620-7.
8. Tefferi A, Chin-Yang Li, Witzig TE, Dhodapkar MV, Okuno SH, Phyliky RL. Chronic natural killer cell lymphocytosis: A descriptive clinical study. Blood 1994; 84:2721-5.
9. Harris NL, Jaffe E, Stein H, et al. A revised European-American Classification of lymphoid neoplasms: a proposal from the International Lymphoma Group. Blood 1994; 84:1361-92.
10. Scott CS, Richards SJ, Sivakumaran M, et al. Transient and persistent expansions of large granular lymphocytes (LGL) and NK-associated (NKa) cell: The Yorkshire Leukemia Group study. Br J Haematol 1993; 83: 504-15.
11. Okuno SH, Tefferi A, Hanson CA, Katzmann JA, Li CY. Spectrum of diseases associated with increased proportions or absolute numbers of peripheral blood natural killer cells. Br J Haematol 1996; 93:810-2.
12. Zambello R, Trentin L, Facco M, et al. The analysis of T cell receptor in the lymphoproliferative disease of granular lymphocytes. Superantigen activation of clonal CD3+ granular lymphocytes. Cancer Res 1995; 55:6140-5.
13. Moretta A, Bottino C, Pende D, et al. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J Exp Med 1990; 172: 1589-98.
14. Zambello R, Trentin L, Ciccone E, et aL Phenotypic diversity of natural killer populations in patients with NK-type lymphoproliferative disease of granular lymphocytes. Blood 1993; 81:2381-5.
15. Semenzato G, Zambello R, Starkebaum G, Oshimi K, Loughran TP Jr. The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood 1997; 89:256-60.
16. Posnett DN, Sinha R, Kabak S, Russo C. Clonal population of T cells in normal ederly humans: the T cell equivalent to "benign monoclonal gammopathy". J Exp Med 1994; 179:609-17, (published erratum appears inj Exp Med 1994; 179:1077).
17. Fitzjerald JE, Ricalton NS, Meyer A-C, et al. Analysis of clonal CD8+ T cell expansions in normal individuals and patients with rheumatoid arthritis. J Immunol 1994; 154:3538-42.
18. Loughran TP JR, Starkebaum G, Kidd P, Neiman P. Clonal proliferation of granular large lymphocytes in rheumatoid arthritis. Arthritis Reum 1988; 31:31-6.
19. Freimark B, Lanier L, Phillips J, Quertermous T, Fox R. Comparison of T cell receptor gene rearrangements in patients with large granular T cell leukemia and Felty's syndrome. J Immunol 1987; 138:1724-9.
20. Snowden N, Bhavnani M, Swinson DR. Large granular T lymphocytes, neutropenia and polyarthropathy: an underdiagnosed syndrome. Q J Med 1991; 78:66-75.
21. Starkebaum G, Loughran TP Jr, Gaur LK, et al. Immunogenetic similarities between patients with Felty's syndrome and those with clonal expansion of large granular lymphocytes in rheumatoid arthritis. Arthritis Rheum 1997; 40:624-6.
22. Zambello R, Loughran TP Jr, Trentin L, et al. Serologie and molecular evidence for a possible pathogenetic role of viral infection in CD3-negative NK-type lymphoproliferative disease of granular lymphocytes. Leukemia 1995, 9: 1207-11.
23. dim+/- phenotype associated with hairy cell leukemia. Haematologica 1995; 80:146-9.
24. Borgonovo G, Secondo V, Varaldo E, Pistoia V, Gobbi M, Mattioli FP. Large granular lymphocyte leukemia associated with hepatocellular carcinoma: a case report. Haematologica 1996; 81:172-4.
25. Dolstra H, Preijers F, Van de Wiehl-Van Kemenade E, et al. Expansion of CD8+CD57+ T cells after allogeneic BMT is related with a low incidence of relapse and with cytomegalovirus infection. Br J Haematol 1995; 90:300-7.
26. Gentile TC, Uner AH, Loughran TP Jr. Chronic CD3+ large granular lymphocyte (LGL) leukemia developing after renal transplantation [abstract]. Blood 1997; 90 (suppl 1):2289a.
27. Lackowski D, Koberda J, Lucas S, DeLoughery TG. Natural killer cell proliferation as a cause of peripheral neuropathy [abstract]. Blood 1997; 90 (suppl 1):2964a.
28. Palutke M, Eisemberg L, Kaplan J, et al. Natural killer and suppressor T cell lymphocytic leukemia. Blood 1983; 62:627-34.
29. Tanaka M, Suda T, Haze K, et al. Fas ligand in human serum. Nature Med 1996; 2:317-22.
30. Nagasawa T, Abe T, Nakagawa T. Pure red cell aplasia and hypogammaglobulinemia associated with Tγ-chronic lymphocytic leukemia. Blood 1981; 57:1025-31.
31. Bassan R, Pronesti M, Buzzatti M, et al. Autoimmunity and B cell dysfunction in chronic proliferative disorders of large granular lymphocytes/ natural killer cells. Cancer 1988; 63:90-5.
32. Gentile TC, Uner AH, Hutchinson RE, et al. CD3+, CD56+, aggressive variant of large granular lymphocyte leukemia. Blood 1994; 84:2315-21.
33. Tefferi A, Greipp PR, Leibson PJ, Thibodeau SN. Demonstration of clonality, by X-linked DNA analysis, in chronic natural killer cell lymphocytosis and successful therapy with oral cyclophospnamide. Leukemia 1992; 6:477-80.
34. Nash R, McSweeney P, Zambello R, Semenzato G, Loughran TP Jr. Clonal studies of CD3-negative lymphoproliferative disease of granular lymphocytes. Blood 1993; 81:2363-8.
35. Kawa-Ha K, Ishihara S, Ninomiya T, et al. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest 1989; 84:51-5.
36. Hart DNJ, Baker BW, Inglis MJ, et al. Epstein-Barr viral DNA in acute large granular lymphocyte (natural killer) leukemic cells. Blood 1992; 79:2116-20.
37. Lanier LL, Phillips JH. Inhibitory class I receptors on NK cells and T cells. Immunol Today 1996; 17:86-91.
38. Lopez-Botet M, Moretta L, Strominger J. NK-cell receptors and recognition of MHC class I molecules. Immunol Today 1996; 17:212-5.
39. Quiròs-Roldan E, Sottini A, Gulletta M, et al. The T-cell receptor repertoires expressed by CD4+ and CD4-large granular lymphocytes derived from the same patients suggest the persistent action of an immune-mediated selection process. Blood 1996; 88:2133-9.
40. Kasten-Sportes C, Zaknoen S, Steis RG, Chan WC, Winton EF, Waldmann TA. T cell receptor gene rearrangement in T-cell large granular leukocyte leukemia: preferential Vα but diverse Jα usage in one of five patients. Blood 1994; 83:767-75.
41. Hoshino S, Oshimi K, Teramura M, Mizoguchi H. Activation via the CD3 and CD16 pathway mediates interleukin-2 dependent autocrine proliferation of granular lymphocytes in patients with granular lymphocyte proliferative disorders. Blood 1991; 78:3232-40.
42. Zambello R, Cassatella M, Trentin L, et al. Different mechanisms of activation of proliferating CD3+ cells in patients with lymphoproliferative disease of granular lymphocytes. Leukemia 1991; 5:942-50.
43. Zambello R, Facco M, Trentin L, et al. Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes. Blood 1997; 89:200-11.
44. Zambello R, Loughran TP Jr, Trentin L, et al. Spontaneous resolution of p58/EB6 antigen restricted NK-type lymphoproliferative disease of granular lymphocytes: role of Epstein Barr virus infection. Br J Haematol 1987; 99:215-21.
45. Pellenz M, Zambello R, Semenzato G, Loughran TP Jr. Detection of Epstein Barr virus by PCR analysis in lymphoproliferative disease of granular lymphocytes. Leuk Lymphoma 1996;, 18:179-84.
46. Kanegane H, Wado T, Nunogami K, Seki H, Taniguchi N, Tosato G. Chronic persistent Epstein-Barr virus infection of natural killer cells and B cells associated with granular lymphocyte expansion. Br J Haematol 1996; 95:116-22.
47. Loughran TP Jr, Coyle T, Sherman MP, et al. Detection of human T-cell leukemia/lymphoma virus, type II, in a patient with LGL leukemia. Blood 1992; 80:1116-20.
48. Loughran TP Jr, Hadlock KG, Yang Q, et al. Seroreactivity to an envelope protein of human T cell leukemia/lymphoma virus in patients with CD3- (NK) lymphoproliferative disease of granular lymphocytes. Blood 1997; 90:1977-81.
49. Pandolfi F, Loughran TP Jr, Starkebaum G, et al. Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes. A multicenter study. Cancer 1990; 65:341-8.
50. Winton EF, Chan WC, Check I, Colendab KW, Bongiovanni KF, Waldman TA. Spontaneous regression of a monoclonal proliferation of large granular lymphocytes associated with reversal of anemia and neutropenia. Blood 1986; 67:1427-32.
51. Loughran TP Jr, Kidd PG, Starkebaum G. Treatment of large granular lymphocyte leukemia with oral low dose methotrexate. Blood 1994; 84:2164-70.
52. Yamamoto T, Iwasaki T, Watanabe N, et al. Expression of multidrug resistance P-glycoprotein on peripheral mononuclear cells of patients with granular lymphocyte proliferation disorders. Blood 1993; 81:1342-6.